Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema


EROL N., Gursoy H. H., Kimyon S., Topbas S., ÇOLAK E.

ADVANCES IN THERAPY, vol.29, no.4, pp.359-369, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.1007/s12325-012-0009-9
  • Journal Name: ADVANCES IN THERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.359-369
  • Keywords: Bevacizumab, Central macular thickness, Diabetic macular edema, Diabetic retinopathy, Foveal avascular zone, Intravitrealinjection, Visual acuity, VISUAL-ACUITY, AVASTIN, PHOTOCOAGULATION, RETINOPATHY, THERAPY, MICROCIRCULATION, IMPAIRMENT
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

To investigate three monthly intravitreal bevacizumab (IVB) injections effects in chronic diabetic macular edema (DME).